Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Shoshana Rosenberg, ScD, MPH


Medical Oncology/Population Sciences

No Ratings Available - Why Not?

Researcher

  • Assistant Professor of Medicine, Dana-Farber Cancer Institute
  • Assistant Professor of Medicine, Harvard Medical School

Contact Information

  • Office Phone Number617-582-7593

Bio

Dr. Rosenberg received her BA from Binghamton University, completed a Master of Public Health degree at NYU and a Doctor of Science degree in Epidemiology at the Harvard T.H. Chan School of Public Health. Following an NCI post-doctoral fellowship in Cancer Prevention, a joint program between the Harvard T.H Chan School of Public Health and Dana-Farber Cancer Institute, she was appointed to the faculty of Dana-Farber Cancer Institute and Harvard Medical School.

Fellowship:

  • DFCI/HSPH

Research

Our research focuses on improving the care and outcomes of young women with breast cancer



I am a cancer epidemiologist with an interest in the unique issues affecting young women with breast cancer; my research focuses on survivorship, quality of life, and treatment decision-making in this population. Intervention development is a core focus of my research. In 2015, I was awarded a K01 career development grant by the Agency for Healthcare Research and Quality to conduct a mixed-methods study that aims to ultimately improve the quality of the surgical decision-making process for young women with breast cancer. As part of this project, I am leading a pilot study of a decision aid intervention for newly-diagnosed young women considering their breast cancer surgical options. 



Incorporating patient-reported outcomes (PROs) into both observational and intervention trials has also been an important focus of my work and this experience will help inform survey development for the proposed project. As a member of the Alliance for Clinical Trials in Oncology - Health Outcomes Committee as well as the Translational Breast Cancer Research Consortium PRO Working Group, I advise clinical trialists on how best to implement PROs into the design of clinical trials. Additionally, I am a co-investigator for a PCORI contract, where I help lead the study aim that will examine PROs among women who are diagnosed with DCIS.

Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial. J Clin Oncol. 2021 Jul 20; 39(21):2375-2385.
View in: PubMed

Impact of fertility concerns on endocrine therapy decisions in young breast cancer survivors. Cancer. 2021 Apr 22.
View in: PubMed

Arm Morbidity After Local Therapy for Young Breast Cancer Patients. Ann Surg Oncol. 2021 Apr 21.
View in: PubMed

Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID-19. Oncologist. 2021 Apr 15.
View in: PubMed

Surgical Treatment after Neoadjuvant Systemic Therapy in Young Women with Breast Cancer: Results from a Prospective Cohort Study. Ann Surg. 2020 Dec 23; Publish Ahead of Print.
View in: PubMed

Pregnancy after breast cancer: Results from a prospective cohort of young women with breast cancer. Cancer. 2021 Apr 01; 127(7):1021-1028.
View in: PubMed

Tumor phenotype and concordance in synchronous bilateral breast cancer in young women. Breast Cancer Res Treat. 2021 Apr; 186(3):815-821.
View in: PubMed

Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancer. Breast Cancer Res Treat. 2021 Feb; 186(1):157-165.
View in: PubMed

Association of Breast Cancer Surgery With Quality of Life and Psychosocial Well-being in Young Breast Cancer Survivors. JAMA Surg. 2020 11 01; 155(11):1035-1042.
View in: PubMed

Prospective evaluation of the impact of stress, anxiety, and depression on household income among young women with early breast cancer from the Young and Strong trial. BMC Public Health. 2020 Oct 06; 20(1):1514.
View in: PubMed

Interventions to Enhance Adherence to Oral Antineoplastic Agents: A Scoping Review. J Natl Cancer Inst. 2020 05 01; 112(5):443-465.
View in: PubMed

Ductal carcinoma in situ (DCIS): The importance of patient-reported outcomes (PRO). Curr Breast Cancer Rep. 2020 Jun; 12(2):90-97.
View in: PubMed

Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer. Clin Cancer Res. 2020 06 01; 26(11):2556-2564.
View in: PubMed

Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer. J Clin Oncol. 2020 03 01; 38(7):725-733.
View in: PubMed

Contemporary management of breast cancer during pregnancy and subsequent lactation in a multicenter cohort of young women with breast cancer. Breast J. 2019 11; 25(6):1104-1110.
View in: PubMed

Employment trends in young women following a breast cancer diagnosis. Breast Cancer Res Treat. 2019 Aug; 177(1):207-214.
View in: PubMed

Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer. Cancer. 2019 09 15; 125(18):3266-3274.
View in: PubMed

Factors Affecting Surgical Decisions in Newly Diagnosed Young Women with Early-Stage Breast Cancer. J Adolesc Young Adult Oncol. 2019 08; 8(4):463-468.
View in: PubMed

Developing a Novel Model to Improve Research and care for Cancer Survivors: a Feasibility Study. J Cancer Educ. 2019 04; 34(2):229-233.
View in: PubMed

Identifying distinct trajectories of change in young breast cancer survivors' sexual functioning. Psychooncology. 2019 05; 28(5):1033-1040.
View in: PubMed

A randomized study to improve care for young women with breast cancer at community and academic medical oncology practices in the United States: The Young and Strong study. Cancer. 2019 06 01; 125(11):1799-1806.
View in: PubMed

Psychosocial needs of young breast cancer survivors in Mexico City, Mexico. PLoS One. 2018; 13(5):e0197931.
View in: PubMed

"I don't want to take chances.": A qualitative exploration of surgical decision making in young breast cancer survivors. Psychooncology. 2018 06; 27(6):1524-1529.
View in: PubMed

Anxiety and Depression in Young Women With Metastatic Breast Cancer: A Cross-Sectional Study. Psychosomatics. 2018 May - Jun; 59(3):251-258.
View in: PubMed

Oncology Physicians' Perspectives on Practices and Barriers to Fertility Preservation and the Feasibility of a Prospective Study of Pregnancy After Breast Cancer. J Adolesc Young Adult Oncol. 2017 Sep; 6(3):429-434.
View in: PubMed

Looking back, moving forward: the evolution of cancer survivorship care. Lancet Oncol. 2017 01; 18(1):18-19.
View in: PubMed

Contralateral prophylactic mastectomy and quality of life: answering the unanswered questions? Gland Surg. 2016 Jun; 5(3):261-2.
View in: PubMed

BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer. JAMA Oncol. 2016 Jun 01; 2(6):730-6.
View in: PubMed

Perceptions, Attributions, and Emotions Toward Endocrine Therapy in Young Women with Breast Cancer. J Adolesc Young Adult Oncol. 2016 Mar; 5(1):16-23.
View in: PubMed

Management of breast cancer in very young women. Breast. 2015 Nov; 24 Suppl 2:S154-8.
View in: PubMed

Breast Cancer in Young Women: Rare Disease or Public Health Problem? JAMA Oncol. 2015 Oct; 1(7):877-8.
View in: PubMed

New Insights Into Nonadherence With Adjuvant Endocrine Therapy Among Young Women With Breast Cancer. J Natl Cancer Inst. 2015 Oct; 107(10).
View in: PubMed

Health care utilization, lifestyle, and emotional factors and mammography practices in the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2015 Nov; 24(11):1699-706.
View in: PubMed

Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer. Ann Surg Oncol. 2015 Nov; 22(12):3809-15.
View in: PubMed

Symptoms and Symptom Attribution Among Women on Endocrine Therapy for Breast Cancer. Oncologist. 2015 Jun; 20(6):598-604.
View in: PubMed

Partner support and anxiety in young women with breast cancer. Psychooncology. 2015 Dec; 24(12):1679-85.
View in: PubMed

Contralateral Prophylactic Mastectomy: An Opportunity for Shared Decision Making. JAMA Surg. 2014 Jun; 149(6):589-90.
View in: PubMed

Treatment-related amenorrhea and sexual functioning in young breast cancer survivors. Cancer. 2014 Aug 01; 120(15):2264-71.
View in: PubMed

Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey. Ann Intern Med. 2013 Sep 17; 159(6):373-81.
View in: PubMed

Contralateral prophylactic mastectomy in women with breast cancer: trends, predictors, and areas for future research. Breast Cancer Res Treat. 2013 Aug; 140(3):447-52.
View in: PubMed

Premature menopause in young breast cancer: effects on quality of life and treatment interventions. J Thorac Dis. 2013 Jun; 5 Suppl 1:S55-61.
View in: PubMed

Preadolescent and adolescent risk factors for benign breast disease. J Adolesc Health. 2013 May; 52(5 Suppl):S36-40.
View in: PubMed

Body image in recently diagnosed young women with early breast cancer. Psychooncology. 2013 Aug; 22(8):1849-55.
View in: PubMed

Research Departments:

Location

Dana 1160
450 Brookline Avenue,
Boston, MA 02215
Get Directions

Top